SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zurich Insurance Group AG (ZURVY) trades at a trailing P/E of 14.9, forward P/E of 14.6. Trailing earnings yield is 6.71%, forward earnings yield 6.85%. PEG 0.83 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (14.9); PEG ≤ 1.0 — Peter Lynch undervalued (0.83); earnings yield beats bond yields (6.71%).
- Forward P/E 14.6 (down from trailing 14.9) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.83 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 6.71% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 6.85% as earnings recover.
Overall SharesGrow Score: 76/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZURVY
Valuation Multiples
P/E (TTM)14.9
Forward P/E14.6
PEG Ratio0.83
Forward PEG6.95
P/B Ratio0.00
P/S Ratio1.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.37
Forward EPS (Est.)$2.42
Book Value / Share$0.00
Revenue / Share$30.61
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.71%
Forward Earnings Yield6.85%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.14 |
$67.33B |
$3.21B |
4.8% |
| 2017 |
$1.99 |
$64.05B |
$3B |
4.7% |
| 2018 |
$2.48 |
$47.2B |
$3.72B |
7.9% |
| 2019 |
$2.77 |
$72.09B |
$4.15B |
5.8% |
| 2020 |
$2.56 |
$58.62B |
$3.83B |
6.5% |
| 2021 |
$3.47 |
$70.07B |
$5.2B |
7.4% |
| 2022 |
$3.08 |
$41.43B |
$3.96B |
9.6% |
| 2023 |
$2.97 |
$74.69B |
$4.35B |
5.8% |
| 2024 |
$2.01 |
$77.75B |
$5.81B |
7.5% |
| 2025 |
$2.37 |
$88.17B |
$6.83B |
7.7% |
